Alumni Profile: James Kang
Gastroenterologist Dr James Kang (Clinical Medicine, 2011) was awarded the 2022-23 Fulbright-Elsevier Data Analytics Award in September 2021. As well as being a Royal Society of Medicine Ellison Cliffe Travelling Fellow, James is using his Fulbright Scholarship to undertake a Master’s in Public Health and a Graduate Certificate in Applied Data Sciences at the University of California, Berkeley. He is also working as a visiting research fellow at Kaiser Permanente, Northern California.
Since qualifying in 2014, James has worked in the East of England, first as an Academic Foundation doctor, then as an NIHR Academic Clinical Fellow and more recently as a Specialist Registrar and Chief Resident at James Paget Hospital. Between hospital shifts, James learned to work with large epidemiological datasets as part of a European cohort study examining the role of nutrition in cancer development.
James is interested in epidemiology and ‘big data’ analytics to improve healthcare delivery and equity. He is currently particularly focused on using big data to develop risk prediction models for early cancer detection and believes such methodology will be applicable to many different health problems.
As a preclinical student James was drawn to GTC by its reputation as ‘the medic college’, owing to its sizeable medical student population and large teaching faculty. Being part of a community of students and tutors with a wide range of medical interests afforded numerous opportunities to gain experience in teaching, audit and research. James benefitted from college funding to attend and present at several medical conferences.
James is especially grateful to former Senior Doll Fellow Dr Laurence Leaver for his support, encouragement, and mentorship throughout his time at GTC. The biggest example of this was a research project as a final year student, in which James came up with the idea, found suitable supervisors and collaborators, wrote the protocol, applied for ethical approval and funding, and carried out the study. Dr Leaver’s guidance was instrumental throughout and helped cement James’ interest in pursuing research as part of his future medical career.
The Radcliffe Observatory has stood for over 250 years.
But heritage requires care and the building now needs restoration to preserve it for future generations.
Support this work by joining the Radcliffe 100 and the Radcliffe 250.
Find out more via the link in our bio 💫
The college is delighted to share the completion of the south landscaping at the Radcliffe Observatory 🌿
This new shared landscape sits at the heart of the Radcliffe Observatory Quarter, made possible by the Stephen A. Schwarzman Foundation.
Work continues on Phase 1 of the Radcliffe Observatory project, including a new main entrance via the East Wing and improved accessibility with step-free access to all entrances.
Three Green Templeton students are heading to one of the world’s most iconic sporting stages 🚣♂️
Congratulations to Julietta Camahort (MSc in Financial Economics, 2025), Louis Corrigan (Clinical Medicine, 2024) and Julian Schoeberl (MSc in Modelling for Global Health, 2025) who have been selected for the Oxford Blues Boats and will face Cambridge this weekend.
Julietta will row for the women’s crew in seat #4, Louis takes the seat as Cox, and Julian joins the men’s crew as the #2 seat.
Wishing them and the Dark Blues the very best of luck 💙
🦖🦴 Major archaeological discovery at the Radcliffe Observatory 🦖🦴
What began as routine landscaping work on the front lawn has taken a rather unexpected turn…
Earlier this week, contractors uncovered what appear to be dinosaur bones.
Initial (very enthusiastic) assessments suggest the remains could belong to a previously unknown species, tentatively named Green Templetonosaurus.
We’ll share further updates as soon as we know more… 🦖
When the researcher becomes the patient.
In this thought-provoking reflection for The Times Magazine, Research Fellow Karl Smith Byrne shares what tackling cancer has taught him both in his work and in his own life.
Diagnosed with rectal cancer at just 27, Karl brings a rare dual perspective to his field, combining research with lived experience to advocate for greater focus on prevention and more patient-centred science.
A compelling insight into resilience and the future of cancer research.
